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The Homeobox Gene GBX2, a Target
of the myb Oncogene, Mediates Autocrine
Growth and Monocyte Differentiation
Elisabeth Kowenz-Leutz,1 Petra Herr,1 activity of such v-myb±containing mutants can be re-
vealed through concomitant expression of the chickenKnut Niss, and Achim Leutz2
Max-DelbruÈ ck-Centrum for Molecular Medicine myelomonocytic growth factor (cMGF), a cytokine that
stimulates the growth and survival of transformed mye-Robert RoÈ ssle Str. 10
13122 Berlin loid cells and colony formation and differentiation of
normal bone marrow cells (Leutz et al., 1984, 1989; MetzGermany
et al., 1991). Thus, myeloid cells transformed by the E26
version of v-myb fail to proliferate in animals because
cMGF is limited, suggesting that the oncogene and theSummary
cytokine cooperate to induce leukemia.
In contrast to E26, the avian myeloblastosis virusThe homeobox gene GBX2 was identified as a target
(AMV) expresses only a truncated v-myb oncogene, whichgene of the v-Myb oncoprotein encoded by the avian
carries multiple point mutations, transforms monoblast-myeloblastosis virus (AMV). GBX2 activation by c-Myb
like cells, and induces a myeloid leukemia in animals.requires signal transduction emanating from the cell
AMV-transformed ªmonoblasts,º although responsivesurface while the leukemogenic AMV v-Myb constitu-
to cMGF, grow in a cMGF-independent manner andtively induces the GBX2 gene. Mutations in the DNA
secrete small amounts of cMGF (Dini et al., 1995; A. L.,binding domain of AMV-Myb render it independent of
unpublished data), suggesting that they grow in an auto-signaling events and concomitantly abrogate the col-
crine fashion. While activation of the cMGF gene in mac-laboration between Myb and CCAAT EnhancerBinding
rophages involves the transcription factors AP1 andProteins (C/EBP), which are involved in granulocyte
C/EBPb (Sterneck et al., 1992b), cMGF expression indifferentiation. Ectopic expression of GBX2 in growth
AMV-transformed cells has been linked to the AMVfactor±dependent myeloblasts induces monocytic fea-
v-Myb DNA binding domain (DBD) (Introna et al., 1989;tures and independence from exogenous cytokines,
Dini et al., 1995). This suggests that the mutations ac-reflecting distinct features of AMV±transformed cells.
quired by AMV v-Myb play an essential role in determin-Ourresults suggest that Myb or factors it interacts with
ing the growth factor independence and hence the leu-contribute to hematopoietic lineage choice and dif-
kemogenicity of the transformed cells.ferentiation in a signal transduction±dependent fashion.
Here we describe that cMGF expression in AMV
monoblasts is induced by GBX2, a homeobox gene that
Introduction we identified as a target for AMV v-myb. Expression of
GBX2 in E26-transformed cells induces morphological
The c-myb gene encodes a transcription factor that and functional monocytic features and allows them to
regulates the growth and differentiation of immature he- grow in the absence of exogenously added growth fac-
matopoietic cells and that is required for mammalian tor, thus reflecting the AMV phenotype. The protoonco-
hematopoiesis (Mucenski et al., 1991; Graf, 1992). Ex- gene c-myb requires an activated system of protein
pression of c-myb is highest in proliferating, immature kinases to induce GBX2. The latter requirement is un-
cells, and it is overexpressed in a variety of leukemias necessary in AMV-transformed cells: the mutations in
and solid tumors (Wolff, 1996). However, ectopic expres- the v-Myb DNA binding domain override the need for
sion of c-myb is not sufficient to induce tumors in cooperating protein kinases, allowing AMV v-Myb to
transgenic animals (Furuta et al., 1993), suggesting that constitutively activate GBX2 and simultanously to abro-
activating mutations are required to reveal its oncogenic gate collaboration with CCAAT enhancer binding pro-
activity (Graf, 1992; Lipsick, 1996). Two different, inde- teins (C/EBP), which are involved in granulocytic differ-
pendently isolated avian leukemia viruses have trans- entiation (MuÈ ller et al., 1995; Zhang et al., 1997). Our
duced v-myb oncogenes that encode mutated, acti- results identify GBX2 as an important downstream tar-
vated Myb proteins and that induce acute leukemias in get of Myb and shed light on the mechanisms of growth
animals (Graf and Stehelin, 1982). Both viruses trans- control and lineage commitment in the hematopoietic
form hematopoietic precursor cells in tissue culture, al- system and the activation of the myb oncogene.
though each displays a unique transformation specific-
ity within the hematopoietic system.
ResultsThe E26 virus encodes a complex chimeric protein in
which v-Myb is fused to a second oncoprotein, v-Ets.
The Homeodomain Protein GBX2 BindsE26 causes a precursor type leukemia with prevail-
the cMGF Promoteringerythroleukemic features and transforms multipotent
One of the most striking features distinguishing AMV-and myeloid progenitors in vitro (Graf et al., 1992). Dele-
and E26-transformed myeloid cells is that only the for-tion of v-ets renders E26 nonleukemogenic in animals.
mer exhibit autocrine growth capacity, caused by theirHowever, the myeloid leukemogenicity and transforming
ability to secrete small quantities of cMGF (Dini et al.,
1995, and A. L., unpublished data). Since the cMGF
promoter lacks binding sites for the Myb protein but1 These authors contributed equally to this work.
2 To whom correspondence should be addressed. nevertheless was activated by AMV but not by E26
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Figure 1. Nuclear Protein Binding to the cMGF Promoter A Site
(A) Scheme of the cMGF promoter and proteins binding to it.
(B) Nuclear extracts from AMV- or E26-transformed cells were incu-
bated with labeled oligonucleotide corresponding to the cMGF pro- Figure 2. GBX2 Protein Expression and Transcriptional Activity
moter A site (lanes 1 and 8). Binding site competition analysis was
(A) Western blot and South-Western analysis of nuclear extracts.
perfomed with 50-fold molar excess of unlabeled competitor oligo-
Immunoblots of nuclear extracts from BM2 cells (lanes 1 and 2) or
nucleotides: B site (lane 2), A site (lanes 3 and 9), AP1 site (lane 4 Cos-7 cells transfected with a GBX2 expression vector (lane 3) using
and 10), DS-260 (lane 5), M1 (lane 6), M2 (lane 7). Oligo sequences rabbit preimmune serum (lane 1) or antiserum raised against recom-
are shown below. Below, oligos A, B, and DS-260 correspond to binant cGBX2 (lanes 2 and 3). South-Western analysis (lanes 4±9)
cMGF promoter sequences as indicated in A. Oligos M1 and M2 using 32P-labeled cMGF promoter A site as a probe. Recombinant,
are mutated versions of the cMGF promoter A site. bacterially expressed GST-GBX2 as control (lanes 4 and 7), nuclear
extracts of BM-2 (lane 5), REV lymphoblast (lane 6, negative control),
vector-transfected Cos cells (lane 8), or Cos cells transfected with
v-Myb (data not shown), we hypothesized that AMV acti- a GBX2 expression vector (lane 9).
vates another transcription factor, which in turn induces (B) Reporter gene activation by GBX2. Luciferase expression from
cMGF. the 295cMGF promoter-luciferase construct or an A site deletion
construct (246cMGF) after transfection into QT6 fibroblasts alongWe used an electrophoretic mobility shift assay to
with or without a GBX2 expression vector as indicated. Bars repre-identify differences in cMGF promoter-binding proteins
sent means of duplicates.in nuclear extracts from AMV- and E26-transformed
myeloblasts. As shown in Figure 1B, an oligonucleotide
probe, which spanned the A site regulatory element cen-
isolated one positive clone that contained a 1.6 kb cDNAtered around position 286 of the cMGF promoter (Ster-
insert. Sequence analysis and data base search re-neck et al., 1992b), shifted a novel, AMV-specific com-
vealed an open reading frame able to encode a homeo-plex (lane 1) in addition to the previously identified AP1
domain protein closely related to GBX2. The highestcomplex present in both cell types (compare lanes 1
protein sequence conservation is located in the homeo-and 8). Competition experiments using canonical AP1
domain, which is identical in thechicken and mammalianoligo (lane 2), the partially overlapping B site (lane 2), or
proteins (data not shown).DS-260, an upstream protein binding site of the cMGF
The GBX2 coding region was expressed as a Glutathi-promoter related to the A site (lane 5), suggested that
one-S-Transferase (GST) fusion protein in E. coli. Thea novel factor expressed in AMV-myeloblasts binds both
recombinant protein bound DNA with a specificity thatto the A site and to a distal site at position 2260 (data
was indistinguishable from that of native complex IInot shown) in the cMGF promoter. Finally, the use of
(data not shown). GST-GBX2 was used as an antigenmutated oligonucleotides revealed that an ATTA core
to prepare both rabbit polyclonal antisera and mousesequence was essential for formation of the complex II
monoclonal antibodies, and these antibodies revealedbut not for binding by AP1.
that the GBX2 protein expressed in transiently trans-
fected Cos-7 cells was localized exclusively in nucleiGBX2 Regulates the cMGF Gene
(data not shown). To analyze GBX2 protein expressionTo identify the factor(s) that form complex II, we used
in more detail, we subjected nuclear extracts from AMV-a multimerized DS-260 oligonucleotide to screena lgt11
transformed cells to Western blotting and to South-cDNA expression library derived from AMV-transformed
BM2 cells. We screened a total of 1.6 3 105 phages and Western analyses (Figure 2A). Extracts from transfected
myb, GBX2, and Hematopoiesis
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Cos-7 cells expressing the GBX2 cDNA and Reticuloen-
dotheliosis virus (REV)±transformed preB/T cells served
as positive and negative controls, respectively. The
GBX2 cDNA encoded proteins of three different sizes
(lane 3), migrating at approximately 45, 43, and 38 kDa
(p45, p43, and p38, respectively), all of which were also
detected in Western blots of AMV-transformed myelo-
blasts (lane 2). The same proteins were also detected
in South-Western blot assays, using a radiolabled oligo-
nucleotide probe derived from the cMGF promoter A
site as a probe (lanes 5 and 9), suggesting that all three
GBX2 forms are expressed in vivo, and all are able to
bind specifically to DNA. To confirm that GBX2 can regu-
late the cMGF promoter, we examined whether ectopi-
cally expressed GBX2 can induce reporter expression.
As shown in Figure 2B, GBX2 activated reporter expres-
sion from the cMGF minimal promoter when the GBX2
binding site was present, but not when it was deleted.
Thus, GBX2 protein binds specifically to DNA and acti-
vates transcription from the cMGF promoter.
GBX2 Expression in Hematopoietic Cells
We used a semiquantitative RT-PCR procedure to ana-
lyze the expression of bothGBX2 and the closely related
GBX1 (also known as cHox7) genes in various chicken
tissues as shown in Figure 3A. As expected, we found
that both genes were expressed in brain, consistent with
reports of murine GBX gene expression (Murtha et al., Figure 3. Expression Analysis of Chicken and Human GBX Genes
1991; Bulfone et al., 1993). In addition, we found GBX1 (A) RT-PCR assay of various tissues derived from 13-day-old
chicken. RNA was extracted, reverse transcribed, and amplifiedbut not GBX2 to be expressed in skeletal muscle. In
using specific primers for GBX1, GBX2, and GAPDH, respectively.contrast, GBX2 but not GBX1 was detected in all he-
PCR fragments were labeled by inclusion of 0.5 mCi of [a32P] dCTPmatopoietic tissues examined including bone marrow,
into the reaction. PCR cycles (30 and 14) were performed to amplify
bursa of fabricius, liver, spleen, and thymus. GBX and GAPDH transcripts, respectively. Cycle number was in the
Next, we used Northern blot analysis to determine linear amplification range for each of the transcripts.
the expression of both GBX genes in various cell lines. (B) Northern analysis of polyA-enriched RNA from chicken cell lines
as indicated using the 39 untranslated GBX2 cDNA as a probe.Figure 3B shows expression of GBX2 mRNA in blast-like
(C) RT-PCR analysis (30 cycles) of human hematopoietic cell linescells of the myelomonocytic, erythroid, and lymphoid
using GBX2 specific primers. 1RT, plus reverse transcriptase; 2RT,lineages. Reprobing the blot with a GBX1-specific probe
without reverse transcriptase; 1NciI, restriction enzyme digest as an
did not reveal expression in any of the hematopoietic cell additional control shows characteristic GBX2 restriction fragments
lines examined (data not shown). To determine whether (RF). Marker lane indicates fragment sizes in bp.
hematopoietic expression of GBX2 occurs in higher ver-
tebrates, we examined various human hematopoietic
remains inactive on estrogen receptor targets. Activa-cell lines (Figure 3C). The progenitor cell line K562 and
tion of GBX2 as well as mim-1 occurred with both estro-the B-lymphocyte SKW64 line both expressed GBX2,
gen and OHT, largely excluding effects that might bewhile several others (Jurkat, Raji, Blin; data not shown)
caused by endogenous steroid hormone receptors orwere negative or showed only negligible expression.
the ER moiety of the Myb-chimera. Furthermore, activa-Taken together, these data suggest that GBX2 is ex-
tion occured even when protein synthesis was blockedpressed in several hematopoietic lineages in verte-
with cycloheximide (CHX) prior to hormone treatmentbrates.
(Figure 4B). In contrast, no GBX2 or mim-1 gene activa-
tion was observed in CHX-treated 10.4HD11 cells in theGBX2 Is a myb Target Gene
absence of hormone or in estrogen/OHT-treated paren-To determine whether GBX2 is a myb target gene, we
tal cells (Figure 4C). Taken together, these data suggesttook advantage of a macrophage cell line that har-
that GBX2 is a direct target gene of the v-Myb protein.bors a chimeric estrogen receptor v-Myb fusion protein
The v-Myb protein encoded by AMV contains numer-(v-MybER; 10.4HD11 cells) and that can be conditionally
ous point mutations that contribute to leukemogenicityactivated by estradiol (Burk and Klempnauer, 1991). As
and cMGF-independent growth and that affect theshown in Figure 4, estrogen treatment of 10.4HD11 cells
transformed cell phenotype (Introna et al., 1989; Dini etrapidly induced expression of both GBX2 and mim-1,
al., 1995). We therefore examined the structural require-the first myb target gene identified (Ness et al., 1989).
ments related to the ability of v-Myb to activate GBX2To further explore the specificity of GBX2 activation by
and mim-1 by transfecting a series of Myb mutants intov-mybER, cellswere treatedwith estrogen or hydroxyta-
HD11 macrophages that express both C/EBPa andmoxifen (OHT; Figure 4B), a synthetic estradiol antago-
nist that activates estrogen receptor fusion proteins but C/EBPb (A. Leutz, unpublished data). As shown in Figure
Cell
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Figure 4. Activation of the GBX2 Gene by a Chimeric Myb-Estrogen
Receptor Fusion Protein
(A) The HD11±10.4 cell line, which harbors a recombinant protein
encoding a portion of Myb fused to the hormone binding domain
of the estrogen receptor, was treated with hormone. RNA was ex-
tracted after the indicated time. Blots with polyA-enriched RNA
were sequentially probed with labeled GBX2, mim-1, and GAPDH
fragments.
(B) HD11±10.4 cells were incubated with or without cycloheximide
(CHX, 50 mg/ml) to block translation 15 min prior to the addition of
estrogen (estr.) or hydroxytamoxifen (OHT). RNA was extracted after
5 hr and polyA-enriched RNA was subjected to the analysis.
(C) HD11 control showing that hormone treatment of the parental
cells did not induce GBX2 or mim-1.
5, only AMV v-myb induced GBX2 expression, while all
other Myb proteins with intact transactivation domains
induced mim-1 but not GBX2. These findings agree with
published results showing that E26 v-myb but not AMV
v-myb activates mim-1 (Introna et al., 1989). These re-
sults suggest that AMV v-myb accumulated gain- as
well as loss-of-function mutations, which led simultane-
ously to constitutive activation of GBX2 coupled with the
loss to cooperate with C/EBP. To study this possibility
further, we tested reciprocal exchange mutants between
c-myb and AMV v-myb. As shown in Figure 5B and
summarized in Figure 5C, the ability to induce GBX2
and the inability to activate mim-1 are both dependent
on the AMV-specific point mutations in the v-Myb DNA
binding domain and are independent of changes in the
N- or C-terminal regions of Myb.
c-Myb Requires an Activated Signaling
Pathway to Induce GBX2
Failure of c-myb to activate GBX2 could reflect a change
in target gene specificity of the AMV-myb version or a
transient physiological condition that was not provided
in our experiments shown in Figure 5. The observation
that c-myb expressing v-erbB±transformed erythro- Figure 5. The DBD of v-myb Determines Activation of GBX2 and
blasts also expressed GBX2 (Figure 3B) suggested that mim-1
an activated signal transduction pathway in conjunction (A) Viral, cellular, or truncated Myb expression consructs were tran-
with c-myb might be involved in GBX2 activation. To siently transfected into the HD11 macrophage cell line. Cells were
harvested after 36 hr, and polyA-enriched RNA was blotted andexamine this possibility, we took advantage of cells
examined with GBX2, mim-1, and GAPDH specific probes.transformed by a recombinant retrovirus that harbored
(B) Truncated c-myb, AMV-myb, or domain swap mutants betweenboth, an E26-derived v-myb oncogene, and the human
AMV- and c-Myb were transfected and analyzed as described in (A)
EGF receptor tyrosine kinase (Metz et al., 1991). Figure DBD-AMV/c-myb indicates that the DBD was derived from AMV-
6A shows that activation of the receptor tyrosine kinase myb and the remainder from c-myb. DBDc-myb/AMV indicates that
by murine EGF can induce both GBX2 and cMGF (Metz the DBD was derived from c-myb and the remainder from AMV.
(C) Summary of the constructs and results from (A) and (B).et al., 1991). To further explore a connection between
(D) Protein expression controls of the constructs and transfectionsc-myb and activated signaling pathways, we transfected
shown in (A) and (B).polyoma middle T (POMT) or EJ-ras along with c-myb
into HD11 cells or treated cells with phorbol ester to
activate protein kinase C (PKC). As shown in Figure 6B,
myb, GBX2, and Hematopoiesis
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that GBX2 enhanced the transformation potential of the
E26 oncogene probably by causing at least partial inde-
pendence from exogenously added cMGF.
Next, we characterized the phenotype of E26GBX2-
transformed cells in more detail. We observed that
E26GBX2-transformed colonies were generally more
diffuse in comparison to the compact E26 myelo-
blast colonies (Figure 7A). Approximately 30%-50%
of the E26GBX2-transformed colonies were without a
sharp boundary, indicative of migratory monocytic cells,
whereas .95% of the E26 colonies were extremely
compact. When isolated and grown in liquid medium,
E26GBX2-transformed cells were significantly larger
than E26 myeloblasts (442 fl 6 75 fl versus 305 fl 6 19 fl;
data from 12 clones each). Many E26GBX2-transformed
cells grew as semiadherent cells, reminiscent of the AMV
monoblast-like cells, while E26-transformed cells wereFigure 6. C-Myb Requires an Activated Signal Transduction Path-
way to Induce GBX2 always round and completely nonadherent (Figure 7C).
(A) Bone marrow cells transformed by a recombinant retrovirus en- To determine whether E26GBX2-transformed cells dis-
coding the v-myb moiety of the E26 virus plus the human EGF played monocytic features, we subjected them to
receptor tyrosine kinase were deprived of EGF for 12 hr or grown phagocytosis assays and determined the expression
in the presence of EGF (50 ng/ml).
of several cell surface markers. Figure 7C shows that(B) The HD11 cell line was transfected with expression constructs
E26GBX2- and AMV- but not E26-transformed cells ac-encoding polyoma middle T (POMT) or EJ-ras alone or together with
tively phagocytosed bacteria and latex beads. All cellc-myb. Indicated cells were treated with phorbol ester (TPA) to
activate PKC kinases 8 hr before harvest. RNA expression was types expressed the general myeloid cell surface marker
monitored as in Figures 4 and 5. Myl51±2 (data not shown), but E26GBX2- and AMV-
transformed cells expressed 5±10 fold more MHCII anti-
gen on their surface (Ewert et al., 1984). These data
GBX2 was activated when c-myb was cotransfected show that E26GBX2 cells more closely resemble AMV-
together with POMT or EJ-ras but not by POMT, EJ-ras, transformed monoblasts than E26-transformed myelo-
or c-myb alone or in conjunction with an activated PKC blasts.
pathway. In contrast, activation of mim-1 also required When individual colonies of transformed cells ob-
c-myb but occurred independently of cotransfected tained in the presence of cMGF were reseeded in liquid
EJ-ras, POMT, or phorbol ester treatment through col- medium either with or without cMGF, 11 out of 12
laboration between Myb and C/EBP, which is abun- E26GBX2 clones regrew in the absence of cMGF, while
dantly expressed in HD11 cells (Sterneck et al., 1992b; none of the E26 clones examined were able to grow in
Ness et al., 1993). the absence of added cMGF (data not shown). This
We conclude that c-Myb collaborates with, or is a suggests that the E26-transformed cells remained com-
target of, a signaling pathway originating at the cell pletely cMGF-dependent, but that the E26GBX2-trans-
surface to induce GBX2. The mutations in the DBD of formed cells no longer required exogenous cytokine ad-
the leukemic AMV v-Myb render it independent on such dition for their growth or survival. To determine whether
signals and, as a consequence, lead to the constitutive factor-independent growth was due to autocrine growth
activation of GBX2. Simultaneously, the mutations in the stimulation, we compared growth of both cell types un-
AMV v-Myb DBD abrogate the collaboration between der different conditions. First, pools of approximately 50
Myb and C/EBP, a hallmark of the granulocytic pheno- colonies from E26- or E26GBX2-infected bone marrow
type (MuÈ ller et al., 1995; Zhang et al., 1997). cultures produced in the presence of cMGF were ex-
panded in liquid medium plus cMGF to eliminate selec-
Ectopic Expression of GBX2 in Hematopietic tion for growth factor independence. The resulting cell
Precursor Cells Alters Their Phenotype populations were then reseeded, and their growth was
Having shown that GBX2 is a target gene of AMV v-Myb, monitored either in the presence or absence of cMGF
a major question was whether ectopic expression of (Figure 8A). The E26GBX2-transformed cells grew about
GBX2 would alter the phenotype and cytokine depen- twice as fast in the presence of exogenous cMGF as in
dence of myelomonocytic precursor cells. We therefore its absence. In contrast, E26-transformed control cells
constructed a recombinant retrovirus that encodes were unable to proliferate at all in the absence of
GBX2 in combination with the transforming v-myb-ets cMGF. As shown in Figure 8B, medium conditioned by
gene of the E26 virus (Figure 7A). Primary chicken bone E26GBX2- but not by E26-transformed cells contained
marrow cells were infected with either the recombinant a growth-promoting activity. Furthermore, growth of
E26GBX2 virus, wild-type E26 or AMV viruses, or helper E26GBX2-transformed cells was inhibited by a cMGF-
virus, and infected cells were seeded into semisolid tis- specific antiserum but not by an irrelevant serum (Figure
sue culture medium either in the presence or absence 8C). Addition of excess, recombinant cMGF restored
of cMGF. Table 1 shows that transformed colonies de- cell growth, indicating that inhibition was not mediated
veloped with both E26GBX2 and AMV but not with E26 by antiserum toxicity (Adkins et al., 1984) (data not
shown). We conclude that E26GBX2-transformed cellsvirus in the absence of added cMGF. These results show
Cell
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Figure 7. Morphologic, Functional, and Cy-
tochemical Comparison between E26GBX2-,
E26-, and AMV-Transformed Bone Marrow
Cells
(A) Schematic presentation of the E26GBX2
and E26 viruses. LTR, long terminal repeats;
IRES, internal ribosomal entry site. Below,
morphology of E26 and E26GBX2 colonies.
Bone marrow cells of freshly hatched chicken
were infected and seeded into Methocel cul-
ture medium in the presence of cMGF. Micro-
graphs of transformed colonies were taken
10 days postinfection.
(B) Protein expression in E26GBX2- and E26-
transformed bone marrow cells. Arrows on
the right indicategag-myb-ets and GBX2pro-
teins as revealed by Western blotting of nu-
clear extracts using rabbit antiserum directed
against Myb and a monoclonal mouse anti-
body directed against GBX2.
(C) Colonies from bone marrow transforma-
tion assays were isolated and cells grown in
liquid medium. After 7 days, phase contrast
micrographs (left panel) were taken from
transformed E26GBX2 cells, E26 cells, or
AMV cells as indicated. Cells were subjected
to phagocytosis assays (middle panel) using
bacteria or fluorescent latex beads (insert).
Note that E26GBX2- and AMV- but not E26-
transformed cells are phagocytic. Bar corre-
sponds to 10 mm. Right panel, MHCII antigen
expression revealed by cytofluorometry.
secrete cMGF (or an immunologically related cytokine), of both growth (Figure 8C) and conditioned medium
(data not shown) of E26GBX2-transformed cells.which stimulates the cells to grow through an autocrine
mechanism. However, we cannot currently exclude ex- To rule out the possibility that the observed differ-
ences between E26GBX2- and E26-transformed cellspression of additional, yet unknown cytokines as indi-
cated by partial neutralization by the cMGF antiserum resulted from outgrowth of different target cells, we
examined whether established E26 myeloblasts would
change their phenotype after expression of GBX2.
E26 myeloblasts superinfected with a GBX2-expressingTable 1. Growth of Transformed Colonies and Cytokine
helper-independent retrovirus (Hughes et al., 1987) be-Dependence
came phagocytic and cMGF independent while no such
Colony Numbersa
changes were found in control virus infected or parental
Virus Strain 2cMGF 1cMGF Ratio (2/1 cMGF) E26 cells (data not shown). Taken together, we conclude
from these experiments that GBX2 induces a monoblast,E26 Exp. 1 7 228 0.03
Exp. 2 25 344 0.07 AMV-like phenotype in myelomonocytic precursor cells.
E26GBX Exp. 1 194 291 0.67
Exp. 2 180 311 0.58
AMV Exp. 1 457 510 0.90 Discussion
Exp. 2 610 650 0.94
RAV-2 Exp. 1 0 0 Ð
The v-myb oncogene of the avian myeloblastosis virusExp. 2 0 0 Ð
(AMV) transforms precursor cells of the monocytic lin-
a Number of transformed colonies obtained after infection of 2 3 eage, which secrete the transcriptionally regulated cyto-
106 bone marrow cells.
kine cMGF in an autocrine fashion. We cloned the
myb, GBX2, and Hematopoiesis
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chicken homeobox gene GBX2 and identified it as a
nuclear factor expressed in AMV monocytes that binds
to and activates transcription from the cMGF promoter.
Furthermore, we demonstrated that GBX2 is a myb tar-
get gene and showed that ectopic expression of GBX2
in myeloblasts mediates monocytic differentiation and
growth factor independence, reflecting distinct features
of the AMV v-myb oncogene.
The induction of GBX2 by c-Myb requires an activated
tyrosine kinase pathway originating at the cell surface.
The dependence of Myb on signal transduction during
GBX2 activation is abrogated by mutations present in
the AMV-Myb DBD. The same mutations abrogate the
collaboration between Myb and C/EBP, which pre-
viously was identified as a bipartite switch controlling
the expression of several differentiation-specific genes.
Our data suggest that gain- and loss-of-function muta-
tions in the DBD of Myb are simultaneously required to
convert it into a leukemia gene and to determine the
transformed phenotype.
Induction of the GBX2 Gene Requires Myb
in Conjunction with an Activated
Signaling Pathway
The c-myb protooncogene is required for and controls
adult hematopoiesis (Mucenski et al., 1991). When Figure 8. Growth Analysis of E26GBX2-Transformed Cells
turned into an oncoprotein by mutation, it may constitu- (A) Growth curves. Cell numbers were determined by daily counting
tively exert regulatory functions, which c-Myb carries of E26- or E26GBX2-transformed cells grown in the presence (open
out in a strictly regulated fashion. We have shown that circles) or absence of cMGF (filled circles).
(B) Growth factor production. Conditioned medium was harvestedthis is the case with Myb-induced GBX2 expression.
from E26GBX2 cells (open circles) or E26 myeloblasts (filled circles)While c-Myb is dependent on signal transduction by
maintained in the absence of cMGF for 48 hr. Conditioned mediaRas-like pathways to turn on GBX2, AMV v-myb turns
were then titrated on factor dependent E26 myeloblasts and cell
on the same gene constitutively. Whether c-Myb is the numbers determined after 5 days.
direct target of kinase signaling or whether c-Myb col- (C) Autocrine growth. Growth inhibition induced by the cMGF antise-
laborates with unknown proteins that represent such rum on E26GBX2-transformed cells grown in the absence of cMGF.
NoIS, no immune serum; acMGF, cMGF antiserum; preIS, preim-targets, however, remains to be determined.
mune serum control.Under normal conditions, activation of GBX2 through
Myb occurs through signals emanating at the cell sur-
face. It will therefore be interesting to determine exactly speculate that hematopoietic transcription factors such
as AML1, ets-1,-2, or PU.1 might be involved in suchwhich hematopoietic surface receptors transmit signals
to induce GBX2 expression and how signaling pathways interactions, although preliminary experiments do not
support this speculation.regulate the transcriptional activity of Myb through its
DBD. Currently, our results suggest that Ras-MAP-
kinase pathways are involved although the mechanism Myb and the Regulation of a Homeobox Gene
Of particular importance is the finding that activatedremains to be elucidated.
None of the amino acids mutated in the AMV DBD signaling pathways in conjunction with Myb induce the
expression of a nonclustered homeobox gene. Sinceeither in the wild-type or the mutant configuration can
serve as phosphorylation sites. Therefore, it seems likely GBX2 is involved in the regulation of other genes exem-
plified by the cMGF cytokine, our data also suggest thatthat the activity of Myb is subject to regulation through
allosteric modifications or through interacting proteins, Myb acts as a master regulator in hematopoiesis by
controlling the expression of transcription factors on awhich may or may not require adjacent cis-regulatory
binding sites. Interestingly, the respective AMV point lower hierarchical level.
In the hematopoietic system, a number of homeoboxmutations are positioned on the surface of the Myb DBD
that faces away from the DNA toward the solvent (Ogata genes might participate in the control of cell lineage
commitment, proliferation, differentiation, and leukemiaet al., 1994). In the wild-type version, those positions
are occupied by hydrophobic amino acids that might development (Kehrl, 1994; Shivdasani and Orkin, 1996).
Certain members of the HOXB cluster are expressedform a contiguous hydrophobic furrow. Such a hydro-
phobic surface structure is interrupted in AMV-myb. It in primitive hematopoietic cells, and overexpression of
HOXB4 causes a selective expansion of this compart-therefore seems plausible that the DBD of Myb could
serve as an interaction surface for one or several acces- ment (Sauvageau et al., 1995). Recently, three homeo-
box genes, MEIS1, HOXA7, and HOXA9 were found up-sory protein(s) and that the AMV-myb mutations inter-
fere with some of those interactions. It is tempting to regulated in murine BXH2 leukemia induced by retroviral
Cell
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insertion mutagenesis. Importantly, rearrangement and by regulating different sets of genes in response to ex-
tracellular signals and/or through interactions with dif-translocation of the HOXA9 gene also occurs in human
acute myeloid leukemia, establishing its role in hemato- ferent sets of transcription factors.
poietic transformation (Nakamura et al., 1996a, 1996b).
Several other nonclustered homeodomain genes are Experimental Procedures
also implicated in normal and dysregulated hemato-
Retroviral Constructs and Pseudotypingpoiesis, such as the TCL-3 gene (HOX11), which is re-
The GBX2 cDNA was inserted into an E26 IRES retrovirus constructarranged and up-regulated in rare cases of T-cell acute
and into RCAS-A (Hughes et al., 1987). Chicken embryo fibroblastsleukemia (Hatano et al., 1991; Kennedy et al., 1991), or
were transfected with recombinant and helper virus plasmid (RAV-2)
the MEIS1-related PBX1 gene, which is fused to the E2A and selected in G418 at 0.8 mg/ml as previously described (Metz
transcription factor in pre-B cell lymphoblastic leuke- et al., 1991). RCAS-A±transfected fibroblasts were grown without
selection. Transgene expression was controlled by Western blottingmias characterized by a t(1;19) rearrangement (Kamps
after 10 days, and culture supernatants were stored at 2708C as aet al., 1990; Kamps and Baltimore, 1993). Thus, the ex-
source of virus.pression of individual genes or sets of homeobox genes
in the hematopoietic system areclearly linked to prolifer-
Chicken Tissues, Cell Lines, and Tissue Cultureation and differentiation control.
Tissue was obtained from 13-day-old White Leghorn SPAFAS
It is noteworthy to mention that hematopoietic GBX2 chicken. The HD3 cell line expressing v-erbB and the HD11 cell line
expression is not restricted to the monocytic lineage expressing v-myc have been described (Beug et al., 1979, 1982).
and was also not observed in more mature, v-myc trans- BM-2 is an AMV-transformed monoblast cell line (Moscovici and
Gazzolo, 1982). MH2-transformed cells express v-myc and v-milformed macrophages. It therefore appears that the
(Coll et al., 1983). HD57 cells are E26-transformed progenitors ex-differentiation activity and the expression of GBX2 is
pressing the v-myb-ets oncogene (Graf et al., 1992). The cell linesdynamically regulated, as it is the case with many other
MSB-1 and RPL-12 are T- and B-lymphoblasts, respectively, and
homeodomain proteins. Interestingly, both erythroid were isolated from bird tumors (Beug et al., 1981). REV-NPB4 is a
chicken HD3 cells and progenitor like human K562 cells REV-transformed pre-B/pre-T-cell line expressing the v-rel onco-
express high levels of c-myb, activated tyrosine kinase gene (Beug et al., 1981). CEF38 is a fibroblast cell line (Kaaden,
1977). All cells were grown in Dulbecco's modified Eagle mediumoncogenes (v-erbB and bcr-abl, respectively), and GBX2.
supplemented with 8% fetal bovine serum, 2% heat-inactivatedIt will therefore be of particular interest to examine the
chicken serum, 15 mM HEPES, penicillin, and streptomycin. Cellsfunctions of GBX2 in other hematopoietic lineages and
were maintained in 5% CO2 atmosphere at 398C.to determine correlations between Myb, activated ki-
nase oncogenes, and GBX2 expression in human leuke-
In Vitro Transformation of Bone Marrow Cells
mias. Clearly, the function of GBX2 in hematopoietic Bone marrow cells were prepared from 1- to 10-day-old chickens
growth and differentiation control requires further exam- of the White Leghorn Spafas flock. Cells (2 3 106) were infected
ination, by deleting the gene in mice or by overexpress- with 0.3 ml virus supernatant. The infected cells were seeded in
DMEM suplemented with 0.8% methylcellulose in the presence anding GBX2 in distinct hematopoietic lineages, for ex-
absence of recombinant cMGF (Leutz et al., 1989). After 8±10 days,ample.
transformed colonies were isolated and expanded in liquid culture.
Superinfection (1 3 105 cells) with RCAS-A or RCASAGBX2 virus
was performed 4 days later.
Is Myb Involved in Hematopoietic Lineage
Commitment and Differentiation? Cytokine Assays
Constitutive activation of GBX2 depends on the point Supernatants of cells were harvested, steril filtered, and titrated on
mutations in the AMV v-Myb DBD, which determine the E26 myeloblasts (Leutz et al., 1984). Briefly, E26 test cells were
washed twice with DMEM to remove cMGF. Cells were then seededleukemogenicity and the phenotype of transformed cells
into titrated supernatants in 96-well plates at 2 3 104 cells in 50 ml(Introna et al., 1989). In this regard, it is interesting to
of medium. After 2 days, viable cells were counted. Autocrine growthcompare our results with those obtained by others in
was determined by adding anti-cMGF or preimmune serum at a
two extensive surveys onthe structure/function relation- concentration of 0.5% to the culture medium.
ship of the v-Myb DBD (Introna et al., 1989; Dini et al.,
1995). These studies showed that the monoblast pheno- Phagocytosis, Cytochemical, and
type and the growth factor production segregate with Immunocytochemical Methods
the AMV v-myb DBD configuration. Here we showed Cells were fed with bacteria or FITC-labeled latex beads at a 1:100
ratio for 1±2 hr as describedearlier (Beug et al., 1979). Cytocentrifugethat the same region determines the collaboration with
preparations of cells were stained with a Giemsa-like stain (Diff-C/EBP proteins and the activation of the GBX2 gene.
Quick, Harleco). Cell suface antigen MHCII (Ewert et al., 1984) wasIt therefore appears that Myb together with C/EBP
analyzed by cytofluorometry. Subcellular localization of GBX2 was
commits hematopoietic precursors toward the granulo- determined in transfected Cos-7 cells by indirect immunofloures-
cytic lineage and that GBX2 dominantly determines the cence using the monoclonal anti-GBX2 antibody MC 4±2.2.
monocytic phenotype in myelomonocytic precursors.
This assumption is supported by the data provided in Synthetic Oligonucleotides
Concatemers of the following synthetic oligonucleotide pairs werethis publication and by the observations that activation
used as binding site probes in the expression screening assay: distalof a conditional C/EBPb protein in E26 progenitor cells
site at 2260 (decamer, upper strand), 59-TCGACGGGTGATTAAGACcan induce eosinophilic differentiation (MuÈ ller et al.,
AATGAGGCAC-39; (lower strand) 59-TCGAGTGCCTCATTGTCTTAA1995) and that C/EBPa-deficient mice have no eosino-
TCACCCG-39; proximal site at 290 (tetramer, upper strand), 59-T
phils or neutrophils (Zhang et al., 1997). We therefore CGA CGCGGGTTAATGAGTGACCAC-39; (lower strand) 59-TCGAGT
propose that, in addition to its role in proliferation, Myb GGTCACTCATTAACCCGCG-39; Ap1 site (upper strand), 59-TCGAG
TGACTCAGCGCG-39; (lower strand) 59-TCGACGCGCTGAGTCAC-is involved in the commitment of hematopoietic lineages
myb, GBX2, and Hematopoiesis
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39. The following oligonucleotides were used as gene-specific prim- Nucleic Acid Analysis
ers for the RT-PCR reactions: The GBX2 cDNA was sequenced using dGTP, dITP, and 7-deaza-
GBX2/59 59-TCCAAGGCGGGGGAACCGTCG-39 dGTP reactions in parallel. Poly(A)1 RNA was isolated using
GBX2/39 59-TGCTGGTGCTGACTCCTGAT-39 Dynabeads Oligo(dT)25 (Dynal). RNAwas separated on 1% agarose-
GBX1/59 59-AACCGCTCGGGAGAGCCCGTC-39 formaldehyde gels, transferred to nylon membranes, UV cross-
GBX1/39 59-TGCTGGTGCTGGCTGCGCAC-39 linked, and baked at 808C for 2 hr. The GBX2-specific DNA probe
GAPDH/59 59-CCATGACAACTTTGGCATTG-39 was isolated from phage 30.1 insert following HincII/ EcoRI diges-
GAPDH/39 59-TCCCCACAGCCTTAGCAG-39 tion. The crossreacting GBX homeobox probe was a SstII and HincII
hGBX2/59 59-AAGTACCTCTCCTTGACCGAG-39 fragment. Restriction fragments used as probes for GAPDH, mim-1,
hGBX2/39 59-GCTGACTTCTGATAGCGAACC-39 and cMGF have been described (Leutz et al., 1989; Ness et al.,
1989). Probes were labeled by random priming and hybridized to
Expression Screening and Isolation of GBX2 membranes in QuickHyb (Stratagene) at 688C for 2 hr. Filters were
The chicken BM-2 cell cDNA library constructed in the expression washed twice in 0.2 3 SSC/0.1% SDS at 658C for 15 min and ex-
vector lgt11 was obtained from A. Sippel (University of Freiburg). posed at 2708C. For rehybridization, filters were stripped for 10 min
The library had an average insert size of approximately 1.5 kb. For at 958C in 0.05 3 SSC/0.1% SDS.
lytic growth of bacteriophage l, the standard host strain Y1090 was
used. Bacteriophage infection, plating, and screening were carried
Western and South-Western Analysisout according to published procedures (Singh et al., 1988; Vinson
Protein extracts were prepared by a mini nuclear extract procedureet al., 1988). In brief, bacteriophage fusion protein expression was
(Schreiber et al., 1989). For detection of GBX2 in hematopoieticinduced after 5 hr at 428C by overlaying with IPTG-impregnated
cells, cells were lysed by Dounce homogenization. Proteins werenitrocellulose filters and overnight growth at 378C. Plates were
subjected to reducing 12.5% SDS-PAGE and electrophoreticallychilled, filters were lifted and immersed in HEPES binding buffer
transferred onto PVDF membrane. Membranes were blocked with(25 mM HEPES [pH 7.9], 25 mM NaCl, 5 mM MgCl2, 0.5 mM DTT)
5% nonfat dry milk in TBST (150 mM NaCl, 50 mM Tris-HCl [pH 7.4],supplemented with 8 M urea. After a renaturation step, filters were
0.02% v/v Tween-20) for 2 hr and incubated overnight at 48C withincubated for 2 hr in BLOTTO. Multimerized oligonucleotide probes
monoclonal antibodies at a concentration of 5 mg/ml in blockingwere labeled by nick translation and incubated with filters for 4 hr
solution. Blots were washed three times with TBST, one time in high-in binding buffer. After four washes (a total of 30 min) in binding
salt buffer (0.5 M NaCl, in TBST), and incubated with a horseradishbuffer containing 0.1% sodium pyrophosphate, filters were exposed
peroxidase-coupled second antibody (goat anti-mouse) for 2 hr.at 2708C with intensifying screens. Phages were plaque purified
Following three washes with TBST, immunoreactivity was monitoredand EcoRI inserts subcloned into Bluescript (Stratagene). A chicken
using a chemoluminescence system (ECL, Amersham). Southwest-GBX1 genomic clone was derived from a genomic phage library
ern analysis was performed as described (Singh et al., 1988). Multi-screened with a GBX2 homeobox probe. Sequence analysis con-
merized oligonucleotide probes were labeled by nick translation.firmed the close relationship of our GBX1 isolate with the published
Unspecific competitor poly(dI-dC) was added to a final concentra-partial chox7 sequence (Fainsod and Gruenbaum, 1989).
tion of 5 mg/ml in HEPES binding buffer.
Expression Constructs
The insert of phage clone 30.1 was subcloned into the bacterial Electrophoretic Mobility Shift Assay
vector pGEX-1, and expression of glutathione-S-transferase/GBX2 Double-stranded oligonuleotides were labeled with [a-32P] dCTP
fusion protein (Gst-GBX2) was induced by IPTG. Bacteria were har- (3000 mCi/mmol, Amersham) by fill-in reaction using Klenow DNA
vested and proteins were extracted as described (Smith and John- polymerase and purified by polyacrylamide gel electrophoresis. Nu-
son, 1988). For eukaryotic expression, the phage 30.1 insert was clear extracts (0.5±1 ml) were incubated in a final volume of 10 ml
subcloned into the pCDM8 expression vector. with labeled fragment (0.25±1 ng) for 30 min on ice. For competition
analysis, a 50-fold molar excess of cold oligonucleotides was used.
RT-PCR The reaction mixture was separated on 5% polyacrylamide/bisacry-
Total RNA was prepared from chicken tissue (Chomczynski and lamide (29:1, w/w) gels at 25 mA at room temperature using 0.53
Sacchi, 1987). Total RNA(5 mg) was reverse transcribed using Super- TBE as electophoretic running buffer.
script RNAseH (GIBCO/BRL). Of the resulting cDNA, 5% served as
template for the PCR reactions in 50 ml of 13 Taq polymerase buffer
Acknowledgments
(Pharmacia) in the presence of 200 mM dNTPs, 100 pmol of each
primer, and 1 U Taq polymerase (Pharmacia) with the following
We would like to thank Scott A. Ness for his continous help, criticalprofile: 5 min 958C; 1 min 958C, 1 min 558C, 2 min 728C for 18
comments, corrections, and suggestions on the manuscript. We(GAPDH) or 24 (GBX2, GBX1) cycles; and 10 min 728C. Conditions
are grateful to Thomas Graf and Hartmut Beug for corrections andfor amplification of human GBX2 cDNA were: 50 mM dNTPs, 2 U
suggestions during the final stages of the preparation of the manu-Taq polymerase, 100 pmol primers in 50 ml. To label the PCR prod-
script, to Stephane Ansieau and Christine MuÈ ller for stimulatingucts, each reaction contained 1 mCi of [a-32P] dCTP(3000 mCi/mmol,
discussions, Reinhold FoÈ rster for help with FACscan analysis,Amersham). The samples were run on acrylamide DNA gels, dried,
BaÈ rbel Dierks for technical assistance, and to Brigitte Scherz forand exposed as described above.
secretarial assistance. We thank Albrecht Sippel for providing the
gt11 expression library and K. H. Klempnauer for the 10.4HD11 cellTransient Transfections, Reporter Assay,
line. This research was supported by grants to A. L. from the DFGand Resident Gene Activation Assay
(AL 770/1±1) and NATO (#921331).Plasmids used for transfections were purified twice on CsCl gradi-
ents. QT6 and HD3 cells were transfected using DEAE-dextran as
described previously (Sterneck et al., 1992a). Cos-7 cells were Received July 24, 1997; revised September 10, 1997.
transfected with lipofectin (BRL). To monitor reporter gene activa-
tion, cells were harvested after 24 hr, whole cell lysates were pre- References
pared, and luciferase activity was determined as previously de-
scribed (Sterneck et al., 1992a, 1992b). Activation of endogenous Adkins, B., Leutz, A., and Graf, T. (1984). Autocrine growth induced
genes was determined as previously described (Ness et al., 1993; by src-related oncogenes in transformed chicken myeloid cells. Cell
Kowenz-Leutz et al., 1994). 39, 439±445.
Beug, H., von Kirchbach, A., DoÈ derlein, G., Conscience, J.F., andAntibodies
Graf, T. (1979). Chicken hematopoietic cells transformed by sevenMice and rabbits were immunized with bacterially derived Gst-GBX2
strains of defective avian leukemia viruses display three distinctfusion protein. Preparation of cells producing monoclonal antibod-
phenotypes of differentiation. Cell 18, 375±390.ies and purification of antibodies were done following standard pro-
cedures (Harlow and Lane, 1988). Beug, H., MuÈ ller, H., Grieser, S., DoÈ derlein, G., and Graf, T. (1981).
Cell
194
Hematopoietic cells transformed in vitro by REV-T avian reticuloen- Novel mechanism of C/EBPb (NF-M) transcriptional control: activa-
tion through derepression. Genes Dev. 8, 2781±2791.dotheliosis virus express characteristics of very immature lymphoid
cells. Virology 115, 295±309. Leutz, A., Beug, H., and Graf, T. (1984). Purification and characteriza-
tion of cMGF, a novel chicken myelomonocytic growth factor. EMBOBeug, H., DoÈ derlein, G., Freudenstein, C., and Graf, T. (1982). Eryth-
roblast cell lines transformed by temperature-sensitive mutants of J. 3, 3191±3197.
avian erythroblastosis virus: a model system to study erythroid dif- Leutz, A., Damm, K., Sterneck, E., Kowenz, E., Ness, S., Frank,
ferentiation in vitro. J. Cell Physiol. Suppl. 1, 195±207. R., Gausepohl, H., Pan, Y.C., Smart, J., Hayman, M., et al. (1989).
Molecular cloning of the chicken myelomonocytic growth factorBulfone, A., Puelles, L., Porteus, M.H., Frohman, M.A., Martin, G.R.,
and Rubenstein, J.L. (1993). Spatially restricted expression of Dlx-1, (cMGF) reveals relationship to interleukin 6 and granulocyte colony
stimulating factor. EMBO J. 8, 175±181.Dlx-2 (Tes-1), Gbx-2, and Wnt-3 in the embryonic day 12.5 mouse
forebrain defines potential transverse and longitudinal segmental Lipsick, J.S. (1996). One billion years of Myb. Oncogene 13, 223±235.
boundaries. J. Neurosci 13, 3155±3172. Metz, T., Graf, T., and Leutz, A. (1991). Activation of cMGF expres-
Burk, O., and Klempnauer, K.-H. (1991). Estrogen-dependent alter- sion is a critical step in avian myeloid leukemogenesis. EMBO J.
ations in differentiation state of myeloid cells caused by a v-myb/ 10, 837±844.
estrogen receptor fusion protein. EMBO J. 10, 3713±3719. Moscovici, C., and Gazzolo, L. (1982). Transformation of Hemopoi-
Chomczynski, P., and Sacchi, N. (1987). Single-step method of RNA etic Cells with Avian Leukemia Viruses, Vol. 1 (New York: Raven).
isolation by acid guanidinium thiocyanate-phenol-chloroform ex- Mucenski, M.L., McLain, K., Kier, A.B., Swerdlow, S.H., Schreiner,
traction. Anal. Biochem. 162, 156±159. C. M., Miller, T.A., Pietryga, D.W., Scott, W.J., and Potter, S.S. (1991).
Coll, J., Saulke, S., Martin, P., Braes, M.B., Lagrou, C., Graf, T., A functional c-myb gene is required for normal murine fetal hepatic
Beug, H., Simon, I.E., and Stehelin, D. (1983). The cellular oncogenes hematopoiesis. Cell 65, 677±689.
c-myc, c-myb and c-erb are transcribed in defined types of avian MuÈ ller, C., Kowenz-Leutz, E., Grieser-Ade, S., Graf, T., Leutz, A.
hematopoietic cells. Exp. Cell Res. 149, 151±162. (1995). NF-M (chicken C/EBPbeta) induces eosinophilic differentia-
Dini, P.W., Eltman, J.T., and Lipsick, J.S. (1995). Mutations in the tion and apoptosis in a hematopietic precursor cell line. EMBO J.
DNA binding and transcriptional activation domains of v-Myb coop- 14, 6127±6135.
erate in transformation. J. Virol. 69, 2515±2524.
Murtha, M.T., Leckman, J.F., and Ruddle, F.H. (1991). Detection of
Ewert, D.L., Munchus, S.M., Chen, C.H., Cooper, M.D. (1984). Analy- homeobox genes in development and evolution. Proc. Natl. Acad.
sis of structural properties and cellular distribution of avian Ia anti- Sci. USA 88, 10711±10715.
gen by using monoclonal antibody to monomorphic determinants.
Nakamura, T., Largaespada, D.A., Shaughnessy, J.D., Jenkins, N.A.,J. Immunol. 132, 2524±2530.
and Copeland, N.G. (1996a). Cooperative activation of Hoxa and
Fainsod, A., and Gruenbaum, Y. (1989). A chicken homeo gene with Pbx1-related genes in murine myeloid leukemias. Nat. Genet. 12,
developmentally regulated expression. FEBS Lett. 250, 381±385. 149±153.
Furuta, Y., Aizawa, S., Suda, Y., Ikawa, Y., Nakasgoshi, H., Nishina, Nakamura, T., Legaespada, D.A., Lee, M.P., Johnson, L.A., Ohyash-
Y., and Ishii, S. (1993). Degeneration of skeletal and cardiac muscles iki, K., Toyama, K., Chen, S.J., Willman, C.L., Chen, I.M., Feinberg,
in c-myb transgenic mice. Transgen. Res. 2, 199±207. A.P., et al. (1996b). Fusion of the nucleoporin gene NUP98 to HOXA9
Graf, T. (1992). Myb: a transcriptional activator linking proliferation by the chromosome translocation t(7;11)(p15;p15) in human myeloid
and differentiation in hematopoietic cells. Curr. Biol. 2, 249±255. leukaemia. Nat. Genet. 12, 154±158.
Graf, T., and Stehelin, D. (1982). Avian leukemia viruses. Oncogenes Ness, S.A., Marknell, AÊ ., and Graf, T. (1989). The v-myb oncogene
and genome structure. BBA Rev. Canc. 651, 245±271. product binds to and activates the promyelocyte-specific mim-1
gene. Cell 59, 1115±1125.Graf, T., McNagny, K., Brady, G., and Frampton, J. (1992). Chicken
ªerythroidº cells transformed by the Gag-Myb-Ets-encoding E26 Ness, S.A., Kowenz, L.E., Casini, T., Graf, T., and Leutz, A. (1993).
leukemia virus are multipotent. Cell 70, 201±213. Myband NF-M: combinatorial activators of myeloid genes inheterol-
Harlow, E., and Lane, D. (1988). Antibodies: A Laboratory Manual ogous cell types. Genes Dev. 7, 749±759.
(Cold Spring Harbor, N.Y.: Cold Spring Harbor Laboratory). Ogata, K., Morikawa, S., Nakamura, H., Sekikawa, A., Inoue, T.,
Hatano, M., Roberts, C.W., Minden, M., Crist, W.M., and Korsmeyer, Kanai, H., Sarai, A., Ishii, S., and Nishimura, Y. (1994). Solution struc-
S.J. (1991). Deregulation of a homeobox gene, HOX11, by the t(10;14) ture of a specific DNA complex of the Myb DNA-binding domain
in T cell leukemia. Science 253, 79±82. with cooperative recognition helices. Cell 79, 639±648.
Hughes, S.H., Greenhouse, J.J., Petropoulos, C.J., Sutrave, P. Sauvageau, G., Thorsteinsdottir, U., Eaves, C.J., Lawrence, H.J.,
(1987). Adaptor plasmids simlify the insertion of foreign DNA into Largman, C., Lansdorp, P.M., and Humphries, R.K. (1995). Overex-
helper-independent retroviral vectors. J. Virol. 61, 3004±3012. pression of HOXB4 in hematopoietic cells causes the selective
expansion of more primitive populations in vitro and in vivo. GenesIntrona, M., Ness, S.A., Golay, J., Nakano, T., and Graf, T. (1989).
Dev. 9, 1753±1765.Mutations in v-myb alter the differentiation of myelomonocytic cells
transformed by the oncogene. Cell 63, 1287±1297. Schreiber, E., Matthias, P., MuÈ ller, M.M., and Schaffner, W. (1989).
Rapid detection of octamer proteins with ªmini-extracts,º preparedKaaden, O.R. (1977). Structure and function of virus-induced anti-
from a small number of cells. Nucl. Acids Res. 17, 6419.gens in cultured cells infected with Marek's disease and turkey
herpes viruses II. Isolation of intracellular antigens from infected Shivdasani, R.A., and Orkin, S.H. (1996). The transcriptional control
cells. Med. Microbiol. Immunol. (Berl.) 163, 157±181. of hematopoiesis. Blood 87, 4025±4039.
Kamps, M.P., and Baltimore, D. (1993). E2A-Pbx1, the t(1;19) translo- Singh, H., LeBowitz, J.H., Baldwin, A.S., Jr., and Sharp, P.A. (1988).
cation protein of human pre-B-cell acute lymphocytic leukemia, Molecular cloning of an enhancer binding protein: isolation by
causes acute myeloid leukemia in mice. Mol. Cell Biol. 13, 351±357. screening of an expression library with a recognition site DNA. Cell
52, 415±423.Kamps, M.P., Murre, C., Sun, X.H., and Baltimore, D. (1990). A new
homeobox gene contributes the DNA binding domain of the t(1;19) Smith, D.B., and Johnson, K.S. (1988). Single-step purification of
translocation protein in pre-B ALL. Cell 60, 547±555. polypeptides expressed in Escherichia coli as fusions with glutathi-
one S-transferase. Gene 67, 31±40.Kehrl, J.H. (1994). Homeobox genes in hematopoiesis. Crit. Rev.
Oncol. Hematol. 16, 145±156. Sterneck, E., Blattner, C., Graf, T., and Leutz, A. (1992a). Structure
of the chicken myelomonocytic growth factor gene and specificKennedy, M.A., Gonzalez, S.R., Kees, U.R., Lampert, F., Dear, N.,
Boehm, T., and Rabbitts, T.H. (1991). HOX11, a homeobox-con- activation of its promoter in avian myelomonocytic cells by protein
kinases. Mol. Cell. Biol. 12, 1728±1735.taining T-cell oncogene on human chromosome 10q24. Proc. Natl.
Acad. Sci. USA 88, 8900±8904. Sterneck, E., MuÈ ller, C., Katz, S., and Leutz, A. (1992b). Autocrine
growth induced by kinase type oncogenes in myeloid cells requiresKowenz-Leutz, E., Twamley, G., Ansieau. S., and Leutz, A. (1994).
myb, GBX2, and Hematopoiesis
195
AP-1 and NF-M, a myeloid specific, C/EBP-like factor. EMBO J. 11,
115±126.
Vinson, C.R., LaMarco, K.L., Johnson, P.F., Landschulz, W.H., and
McKnight, S.L. (1988). In situ detection of sequence-specific DNA
binding activity specified by a recombinant bacteriophage. Genes
Dev. 2, 801±806.
Wolff, L. (1996). Contribution of oncogenes and tumor suppressor
genes to myeloid leukemia. BBA Rev. Canc. 1332, 67±104.
Zhang, D., Zhang, P., Wang, N., Hertherington C.J., Darlington, G.J.,
Tenen, D.G. (1997). Absenceof granulocyte colony stimulating factor
signaling and neutrophil development in CCAAT enhancer binding
protein alpha deficient mice. Proc. Nat. Acad. Sci. USA 94, 569±574.
GenBank Accession Number
The accession number for the sequence reported in this paper is
AF022151.
